Showing 81 - 100 results of 163 for search '"polycystic ovary syndrome"', query time: 0.12s Refine Results
  1. 81
  2. 82

    Evaluating the effects of time-restricted eating on overweight and obese women with polycystic ovary syndrome: A randomized controlled trial study protocol. by Hui Liu, Fuliang Shangguan, Fen Liu, Yu Guo, Huixi Yu, Hanbing Li, Yinhua Su, Zhongyu Li

    Published 2025-01-01
    “…<h4>Objective</h4>This study aims to assess the 6-month effects of TRE on weight change, metabolic improvement, reproductive recovery, and health-related quality of life in overweight and obese women with polycystic ovary syndrome (PCOS), compared to those who did not receive TRE.…”
    Get full text
    Article
  3. 83

    Decreased Sex Hormone-Binding Globulin Indicated Worse Biometric, Lipid, Liver, and Renal Function Parameters in Women with Polycystic Ovary Syndrome by Xi Luo, Xin-Ming Yang, Wang-Yu Cai, Hui Chang, Hong-Li Ma, Yan Peng, Xiao-Ke Wu

    Published 2020-01-01
    “…To investigate the relationships between sex hormone-binding globulin (SHBG) and comprehensive metabolic parameters including biometric, glycemic, lipid, liver, and renal functions of women with polycystic ovary syndrome (PCOS). Study Design and Methods. …”
    Get full text
    Article
  4. 84

    miR-124-3p Combined with ANGPTL2 Has High Diagnostic Values for Obese and Nonobese Polycystic Ovary Syndrome by Hongmei Dai, Fangting Liu, Jianshu Lu, Yan Yang, Pingping Liu

    Published 2022-01-01
    “…Polycystic ovary syndrome (PCOS) is a hormonal disorder that affects 5–20% of women of reproductive age. …”
    Get full text
    Article
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89

    Correlation of Endometrial Glycodelin Expression and Pregnancy Outcome in Cases with Polycystic Ovary Syndrome Treated with Clomiphene Citrate Plus Metformin: A Controlled Study by Selda Uysal, Ahmet Zeki Isik, Serenat Eris, Seyran Yigit, Yakup Yalcin, Pelin Ozun Ozbay

    Published 2015-01-01
    “…A total of 30 patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria constituted our study group. …”
    Get full text
    Article
  10. 90
  11. 91
  12. 92

    The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome by Thanyarat Wongwananuruk, Manee Rattanachaiyanont, Pichai Leerasiri, Suchada Indhavivadhana, Kitirat Techatraisak, Surasak Angsuwathana, Prasong Tanmahasamut, Chongdee Dangrat

    Published 2012-01-01
    “…To study the cut-off point of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) as a screening test for detection of glucose intolerance in Thai women with polycystic ovary syndrome (PCOS). Study Design. Cross-sectional study. …”
    Get full text
    Article
  13. 93
  14. 94

    The Use of SenseWear Armband for Assessment of Daily Energy Expenditure and the Relation to Body Fat Distribution and Nutritional Intake in Lean Women with Polycystic Ovary Syndrome by Gulcan Arusoglu

    Published 2020-01-01
    “…To evaluate nutritional intake, energy expenditure, and segmental body composition in lean women with polycystic ovary syndrome (PCOS) and compare them with age- and body mass index- (BMI-) matched control women. …”
    Get full text
    Article
  15. 95
  16. 96

    The Effect of Prebiotics, Alone or as Part of Synbiotics, on Cardiometabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Elham Razmpoosh, Mala S. Sivanandy, Alan M. Ehrlich

    Published 2025-01-01
    “…<b>Background</b>/<b>Objectives</b>: This systematic review and meta-analysis aimed to investigate the effect of prebiotics, alone or as part of synbiotics, on cardiometabolic parameters in polycystic ovary syndrome (PCOS) women. <b>Methods</b>: Databases, including PubMed, Scopus, ISI Web of Science, Embase, and the Cochrane Central Register of Controlled Trials, were searched for relevant randomized-controlled trials (RCTs) until 12 December 2024. …”
    Get full text
    Article
  17. 97
  18. 98
  19. 99

    Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers by Xiufen Zheng, Zikai Chen, Miao Liang, Liting Zhou, Miaoru Wang, Silin Zhang, Shuyun Zhang, Lei Ma, Wei Yi, Xiawen Liu

    Published 2025-01-01
    “…Abstract Background Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder among women of reproductive age. …”
    Get full text
    Article
  20. 100

    The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis by Xiaorui Lyu, Taibiao Lyu, Xue Wang, Huijuan Zhu, Hui Pan, Linjie Wang, Hongbo Yang, Fengying Gong

    Published 2021-01-01
    “…Both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metformin (MET) have markedly antiobesity effects in overweight/obese polycystic ovary syndrome (PCOS) patients. However, there was no literature to compare the antiobesity effects of these two medicines. …”
    Get full text
    Article